Stomper J, Kicinski M, Ma T, Meyer T, et al. Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) and German Br J Haematol 2026 Nov 3. doi: 10.1111/bjh.70874.
PMID: 42977697